- Home
- CPSH vs CGTX Comparison
CPSH vs CGTX Comparison
Compare CPSH & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPSH
- CGTX
- Stock Information
- Founded
- CPSH 1984
- CGTX 2007
- Country
- CPSH United States
- CGTX United States
- Employees
- CPSH N/A
- CGTX N/A
- Industry
- CPSH Building Materials
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- CPSH Consumer Discretionary
- CGTX Health Care
- Exchange
- CPSH Nasdaq
- CGTX Nasdaq
- Market Cap
- CPSH 48.2M
- CGTX 53.4M
- IPO Year
- CPSH 1987
- CGTX 2021
- Fundamental
- Price
- CPSH $3.53
- CGTX $2.17
- Analyst Decision
- CPSH
- CGTX Strong Buy
- Analyst Count
- CPSH 0
- CGTX 3
- Target Price
- CPSH N/A
- CGTX $2.83
- AVG Volume (30 Days)
- CPSH 93.7K
- CGTX 8.0M
- Earning Date
- CPSH 10-29-2025
- CGTX 11-12-2025
- Dividend Yield
- CPSH N/A
- CGTX N/A
- EPS Growth
- CPSH N/A
- CGTX N/A
- EPS
- CPSH N/A
- CGTX N/A
- Revenue
- CPSH $25,764,977.00
- CGTX N/A
- Revenue This Year
- CPSH N/A
- CGTX N/A
- Revenue Next Year
- CPSH N/A
- CGTX N/A
- P/E Ratio
- CPSH N/A
- CGTX N/A
- Revenue Growth
- CPSH 7.46
- CGTX N/A
- 52 Week Low
- CPSH $1.29
- CGTX $0.22
- 52 Week High
- CPSH $3.72
- CGTX $3.83
- Technical
- Relative Strength Index (RSI)
- CPSH 59.73
- CGTX 52.79
- Support Level
- CPSH $3.31
- CGTX $2.33
- Resistance Level
- CPSH $3.54
- CGTX $2.60
- Average True Range (ATR)
- CPSH 0.26
- CGTX 0.34
- MACD
- CPSH -0.02
- CGTX -0.09
- Stochastic Oscillator
- CPSH 65.45
- CGTX 15.31
About CPSH CPS Technologies Corp.
CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.